DOD Biotech PCL

DOD Biotech PCL Interest Coverage

The Interest Coverage Ratio of DOD Biotech PCL (DOD.BK) as of Oct 10, 2026 is 14.49. In the previous year, Interest Coverage Ratio was 11.25 — a change of 28.83% (higher).

Interest Coverage

14.49

YoY

28.83%

Last updated:

Interest Coverage Ratio of DOD Biotech PCL is 2024 14.49 . Interest Coverage Ratio of DOD Biotech PCL was 2023 11.25 . It decreases by 28.83% higher compared to the previous year.

The DOD Biotech PCL Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
39.39 THB
Jan 1, 2018
83.44 THB
Jan 1, 2019
11.00 THB
Jan 1, 2020
15.83 THB
Jan 1, 2021
93.33 THB
Jan 1, 2022
-59.70 THB
Jan 1, 2023
11.25 THB
Jan 1, 2024
14.49 THB
The DOD Biotech PCL Interest Coverage history
YEARInterest CoverageYoY
14.49+28.83%
11.25-118.84%
-59.70-163.97%
93.33+489.48%
15.83+43.97%
11.00-86.82%
83.44+111.86%
39.39-79.03%
187.82-91.58%
2,229.62—
Access this data via the Eulerpool API

DOD Biotech PCL Stock analysis

What does DOD Biotech PCL do? DOD Biotech PCL is a Thai biotechnology company specializing in the production of pharmaceuticals, diagnostics, and research products. Established in 2004, the company has become one of the most reputable biotechnology companies in Thailand. Its business model is based on the development and manufacturing of products used in medicine, veterinary medicine, and research. DOD Biotech PLC focuses on continually evolving and adapting its products to meet customer needs. Its main areas of focus are the production of pharmaceuticals, particularly anti-cancer drugs, diabetes medications, cardiovascular medications, and infection treatments. Additionally, the company manufactures diagnostics for disease early detection and precise diagnosis. It also offers a variety of products for research purposes. DOD Biotech PCL has partnerships with several companies in other countries, particularly in Asia and Europe. Its largest partner is the Indian company Sun Pharma, with which it has had a successful collaboration for many years. The company is known for its high-quality standards and is certified to ISO 9001:2015 and follows the Good Manufacturing Practices (GMP) required by the Thai FDA. DOD Biotech PCL has received international recognition, including the Frost & Sullivan Thailand Excellence Award and being recognized as a top 30 company in Thailand in 2020. Over the years, the company has built a loyal customer base that appreciates its high-quality products and excellent customer service. It has a strong online presence to better reach and serve its customers. In summary, DOD Biotech PCL is a leading biotechnology company in Thailand with a wide range of pharmaceuticals, diagnostics, and research products. It has earned an excellent reputation for its high-quality standards and top-notch customer service. With its strong online presence and partnerships with other companies in Asia and Europe, DOD Biotech PCL will undoubtedly remain an important player in the global healthcare market in the future. DOD Biotech PCL is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DOD Biotech PCL stock

Interest Coverage Ratio of DOD Biotech PCL is 14.49 in 2024.

Interest Coverage Ratio of DOD Biotech PCL changed from 11.25 to 14.49, representing a 28.83% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio DOD Biotech PCL since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's DOD Biotech PCL with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — DOD Biotech PCL

All Key Metrics — DOD Biotech PCL